Hee‐Chang Jang
Impact in
- Infectious Diseases top 1%
- Antifungal resistance and susceptibility
- Antimicrobial Resistance in Staphylococcus
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
Papers in
-
- Antimicrobial Resistance in Staphylococcus 22
- COVID-19 Clinical Research Studies 14
- SARS-CoV-2 and COVID-19 Research 14
- Antifungal resistance and susceptibility 8
-
- Antibiotic Resistance in Bacteria 17
- Co-authors
- Sook‐In JungUh Jin KimSeung‐Ji KangKyung‐Hwa ParkJong Hee ShinKyung Hwa ParkSoo Hyun KimWee Gyo Lee
- Journals
- Journal of Korean Medical Science (12 papers)PLoS ONE (8 papers)Antimicrobial Agents and Chemotherapy (6 papers)Open Forum Infectious Diseases (5 papers)BMC Infectious Diseases (4 papers)
- Partner nations
- South KoreaEthiopiaJapan
In The Last Decade
Hee‐Chang Jang
116 papers receiving 2.5k citations
Hit Papers
Peers
Comparison fields: 5 of 120
- Infectious Diseases 1.5k
- Applied Microbiology and Biotechnology 101
- Clinical Biochemistry 326
- Molecular Medicine 234
- Endocrinology 178
Countries citing papers authored by Hee‐Chang Jang
This map shows the geographic impact of Hee‐Chang Jang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hee‐Chang Jang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hee‐Chang Jang more than expected).
Fields of papers citing papers by Hee‐Chang Jang
This network shows the impact of papers produced by Hee‐Chang Jang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hee‐Chang Jang. The network helps show where Hee‐Chang Jang may publish in the future.
Co-authors
The 25 scholars most cited alongside Hee‐Chang Jang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 2 | |
| 2 | 2023 | 0 | |
| 3 | 2023 | 3 | |
| 4 | 2020 | 8 | |
| 5 | 2020 | 17 | |
| 6 | 2020 | 31 | |
| 7 | 2020 | 5 | |
| 8 | 2020 | 2 | |
| 9 | 2019 | 6 | |
| 10 | 2019 | 7 | |
| 11 | 2018 | 21 | |
| 12 | 2018 | 0 | |
| 13 | 2018 | 5 | |
| 14 | 2018 | 16 | |
| 15 | 2017 | 28 | |
| 16 | 2016 | 23 | |
| 17 | 2016 | 28 | |
| 18 | 2013 | 27 | |
| 19 | Clinical and Microbiological Features Were Different Between Bacteremic Staphylococcus aureus With and Without Agr Function | 2008 | 1 |
| 20 | Two Cases of Anal Cancer in Patient with Acquired Immunodeficiency Syndrome Infected by Human Papillomavirus | 2005 | 1 |
About Hee‐Chang Jang
Hee‐Chang Jang is a scholar working on Infectious Diseases, Molecular Medicine, Endocrinology, Clinical Biochemistry and Epidemiology, having authored 119 papers that have together received 2.6k indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (22 papers), Bacterial Identification and Susceptibility Testing (17 papers), Antibiotic Resistance in Bacteria (17 papers), COVID-19 Clinical Research Studies (14 papers), SARS-CoV-2 and COVID-19 Research (14 papers), Streptococcal Infections and Treatments (12 papers), Antifungal resistance and susceptibility (8 papers) and Vibrio bacteria research studies (8 papers). The work is most often cited by research in Infectious Diseases (1.5k citations), Applied Microbiology and Biotechnology (101 citations), Clinical Biochemistry (326 citations), Molecular Medicine (234 citations) and Endocrinology (178 citations). Hee‐Chang Jang has collaborated with scholars based in South Korea, Ethiopia and Japan. Frequent co-authors include Sook‐In Jung, Uh Jin Kim, Seung‐Ji Kang, Kyung‐Hwa Park, Jong Hee Shin, Kyung Hwa Park, Soo Hyun Kim, Wee Gyo Lee, Min Gu Kang and Myoung‐don Oh. Their work appears in journals such as Journal of Korean Medical Science, PLoS ONE, Antimicrobial Agents and Chemotherapy, Open Forum Infectious Diseases and BMC Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.